↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
7 news outlets
blogs
2 blogs
twitter
68 X users
guideline
3 clinical guideline sources

Readers on

mendeley
215 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Published in
Journal of Clinical Oncology, September 2017
DOI 10.1200/jco.2017.73.5324
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 68 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Portugal 1 <1%
Unknown 214 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 24 11%
Student > Postgraduate 24 11%
Student > Master 21 10%
Other 20 9%
Student > Doctoral Student 16 7%
Other 42 20%
Unknown 68 32%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 89 41%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Agricultural and Biological Sciences 8 4%
Biochemistry, Genetics and Molecular Biology 7 3%
Nursing and Health Professions 6 3%
Other 13 6%
Unknown 83 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 108. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2024.
All research outputs
#497,782
of 34,669,485 outputs
Outputs from Journal of Clinical Oncology
#1,026
of 32,833 outputs
Outputs of similar age
#7,879
of 355,182 outputs
Outputs of similar age from Journal of Clinical Oncology
#30
of 126 outputs
Altmetric has tracked 34,669,485 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,833 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 126 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.